Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1998-06-16
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 514826, 514885, 514886, 424 851, A61K 3804
Patent
active
057670650
ABSTRACT:
Mammalian Interleukin-4 receptor proteins find use in inhibiting biological activities of IL-4. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
REFERENCES:
patent: 4551433 (1985-11-01), DeBoer
patent: 4675285 (1987-06-01), Clark et al.
patent: 4683199 (1987-07-01), Palladino
patent: 5246701 (1993-09-01), Dugas et al.
patent: 5449756 (1995-09-01), Taniguchi et al.
Ohara and Paul, "Receptors for B-cell stimulatory factor-1 expressed on cells of haematopietic lineage", Nature 325:537-540, 1987.
Park et al., "Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1", Proc. Nat. Acad. Sci. USA, 84:1669-1673, 1987.
Park et al., "Characterization of the Human B Cell Stimulatory Factor 1 Receptor", J. Exp. Med., 166:476-488, 1987.
Nakajima et al., "Detection of Receptors for Murine B Cell Stimulatory Factor 1 (BSF1): Presence of Functional Receptors on CBA/N Splenic B Cells", J. Immunol. 139:774-779, 1987.
Cabrillat et al., "High Affinity Binding of Human Interleukin 4 to Cell Lines", Biochem. & Biophys. Res. Commun. 149:995-1001, 1987.
Lowenthal et al., "Expression of High Affinity Receptors for Murin Interleukin 4 (BSF1)", J. Immunol. 140:456-464, 1988.
Lowenthal et al., "Up-Regulation of Interleukin 4 Receptor Expression on Immature (Lyt-2.sup.- /L3T4.sup.-) Thymocytes", J. Immunol. 140:474-478, 1988.
Park et al., "Interleukin-4 Binds to Murine Fibroblasts: Receptor Characterization and Induction of Colony Stimulating Activity Production", UCLA Symposia Abstracts, J. Cell Biochem. Suppl. 12A, 1988.
Dower et al., "Interleukin Receptors", ISI Atlas of Science: Immunology, 116-120, 1988.
Okayama and Berg, "High-Efficiency Cloning of Full-Length cDNA", Mol. Cell. Biol. 2:161-170, 1983.
Okayama and Berg, "A cDNA Cloning Vector that Permits Expression of cDNA Inserts in Mammalian Cells", Mol. Cell. Biol. 3:280-289, 1983.
Aruffo and Seed, "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system", Proc. Natl. Acad. Sci. USA 84:8573-8577, 1987.
Yamasaki et al., "Cloning and Expression of the Human Interleukin-6 (BSF-2/IFN.beta. 2) Receptor", Science 241:825-828, 1988.
Sims et al., "cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily", Science241:585-589, 1988.
De Maagd et al., "The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies", Immunology 54:745-754, 1985.
Larche et al., "A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment", Immunology 64:101-105, 1988.
Larche et al., "Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor", Immunology 65:617-622, 1988.
Jabaari et al., British J. Cancer 59 (6) 910-914, 1989.
Salari et al., Biochem. J. 262:897-908, 1989.
Urdal et al., "Studies on Hematopoietic Growth Factor Receptors Using Human Recombinant IL-3, GM-CSF, G-CSF, M-CSF, IL-1 and IL-4", Behring Inst. Mitt. 83:27-39, Aug., 1988.
Harada et al., "Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding", Proc. Natl. Acad. Sci. USA 87:857-861, 1990.
Mosley et al., "The Murine Interleukin-4 Receptor: Molecular Cloning and Characterization of Secreted and Membrane Bound Forms", Cell 59:335-348, Oct., 1989.
Finkelman et al., "IL-4 Is Required to Generate and Sustain In Vivo IgE Responses", J. Immunol. 141:2335-2341, 1988.
Finkelman et al., "Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1", Proc. Natl. Acad. Sci. USA 83:9675-9678, 1986.
Snapper et al., "Differential Regulation IgG1 and IgE Synthesis by Interleukin 4", J. Exp. Med. 167:183-196, 1988.
Finkelman et al., "T Help Requirements for the Generation of an In Vivo IgE Response: A Late Acting Form of T Cell Help Other Than IL-4 Is Required for IgE but not for IgG1 Production", J. Immunol. 142:403-408, 1989.
Galizzi et al., "Purification of a 130-kDa T Cell Glycoprotein That Binds Human Interleukin 4 with High Affinity", J. Biol. Chem. 265:439-444, 1990.
Galizzi et al., "Internalization of Human Interleukin 4 and Transient Down-regulation of Its Receptor in the C23-inducible Jijoye Cells", J. Biol. Chem. 264:6984-6989, 1989.
Chester and Hawkins, "Clinical issues in antibody design", Tibtech 13:294-300, 1995.
Paul, William E., Ed., Fundamental Immunology, Raven Press, New York, 1993, p. 826.
Borish et al., "Phase I Nebulization Study of Recombinant Human IL-4 Receptor (rhuIL-4R) in Adult Patients with Mild Atopic Asthma", Abstract for American Academy of Allergy, Asthma and Immunology/AAI/CIS Joint Meeting Feb. 21-26, 1997; published in J. Allergy Clin Immunol 99: S413, Abstract 1678, Jan. 1997.
Borish et al., "Phase I Neubulization Study of Recombinant Human IL-4 Receptor (rhuIL-4R) in Adult Patients with Mild Atopic Asthma", Poster presented at American Academy of Allergy, Asthma and Immunology/AAI/CIS Joint Meeting Feb. 21-26, 1997.
Knight, "Allergy: Big Market, Big Risks", Bio/Technology 8:717-719, Aug. 1990.
Renz et al., "Inhibition of Allergen-Induced IgE and IgG1 Production by Soluble IL-4 Receptor",Int Arch Allergy Immunol 106: 46-54, 1995.
Renz et al., "Inhibition of Allergen-Induced and Allergen-Specific IgE and IgG1 Production by Soluble IL-4 Receptor", J. Allergy Clin Immunol:, p. 234, Abstract 373, Jan. 1993.
Mowat et al., "A role for IL-4 in immunology mediated enteropathy", Clin Exp Immunol 99: 65-69, 1995.
Finkelman et al., "Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody", International Immunology 3: 599-607, Jun. 1991.
Finkelman et al., "Lymphokine Control of In Vivo Immunoglobulin Isotype Selection", Annu. Rev. Immunol. 8: 303-33, 1990.
Ryan, "Interleukin-4 and its receptor: Essential mediators of the allergic response", J. Allergy Clin Immunol 99: 1-5, 1997.
Renz et al., "Enhanced IL-4 Production and IL-4 Receptor Expression in Atopic Dermatitis and Their Modulation by Interferon-Gamma", The Journal of Investigative Dermatology 99: 403-408, Oct. 1992.
Jujo et al., "Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis", J. Allergy Clin Immunol 90: 323-331, Sep. 1992.
Jacobs et al., "Characterization and Pharmacokinetic Parameters of Recombinant Soluble Interleukin-4 Receptor", Blood 77: 2396-2403, Jun. 1991.
Maliszewski et al., "Recombinant Soluble Receptors Specifically Inhibit IL-1 and IL-4 Induced B Cell Activities In Vitro", The Journal of Immunology 144: 3028-3033, Apr. 1990.
Spiegelberg et al., "Role of Interleukin-4 in Human Immunoglobulin E Formation in hu-PBL-SCID Mice", Journal of Clinical Invest. 93: 711-717, Feb. 1994.
Garrone et al., "A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes", Eur. J. Immunol. 21: 1365-1369, 1991.
Fanslow et al., "Regulation of Alloreactivity in Vivo by IL-4 and the Soluble IL-4 Receptor", Journal of Immunology 147: 535-540, Jul. 1991.
Maliszewski et al., "The Interleukin-4 Receptor: Potential Therapeutic Applications in the Allergic Response", Allergy & Clinical Immunology News 2: 86-90, May/Jun. 1990.
Muller et al., "Th2 Cells Mediate IL-4-Dependent Local Tissue Inflammation", The Journal of Immunology 150: 5576-5584, Jun. 1993.
Sato et al., "Recombinant Soluble Murine IL-4 Receptor Can Inhibit or Enhance IgE Responses in Vivo", The Journal of Immunology 150: 2717-2723, Apr. 1993.
Weber et al., "Soluble IL-4 Receptor (sIL-4R) Modulates the Effects of IL-4 on HIV-1 Replication in Human Monocytes", Abstract of poster presented at International Cytokine Society Meeting, Banff, Alberta, Canada, Oct. 1-5, 1994.
Bergese, et al., "Regulation of Endothelial VCAM-1 Expression in Murine Cardiac Grafts", American Journal of Pathology 147: 166-175, Jul. 1995.
Beckmann M. Patricia
Cosman David J.
Idzerda Rejean
March Carl J.
Mosley Bruce
Anderson Kathryn A.
Draper Garnette D.
Immunex Corporation
Wight Christopher L.
LandOfFree
Use of interleukin-4 receptors to inhibit biological responses m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of interleukin-4 receptors to inhibit biological responses m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-4 receptors to inhibit biological responses m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726002